-
Je něco špatně v tomto záznamu ?
Benzothiazoles - scaffold of interest for CNS targeted drugs
L. Hroch, L. Aitken, O. Benek, M. Dolezal, K. Kuca, F. Gunn-Moore, K. Musilek,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
- MeSH
- Alzheimerova nemoc farmakoterapie MeSH
- antikonvulziva chemie diagnostické užití terapeutické užití MeSH
- benzothiazoly chemie diagnostické užití terapeutické užití MeSH
- kvantitativní vztahy mezi strukturou a aktivitou MeSH
- lidé MeSH
- neuroprotektivní látky chemie diagnostické užití terapeutické užití MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Benzothiazole compounds represent heterocyclic systems comprising a benzene ring fused with a thiazole ring containing nitrogen and sulphur in its structure. Besides the presence of a benzothiazole core in naturally occurring molecules, synthesized compounds containing a benzothiazole moiety in their structure proved to be a significant class of potential therapeutics, as they exhibit biological effects such as antitumor, antibacterial, antitubercular, antiviral, anthelmintic, antidiabetic and many others. Apart from the aforementioned peripheral or microbial active sites, benzothiazole analogues are also biologically active compounds in the central nervous system, where some approved drugs containing a benzothiazole moiety have already been identified and are used in the treatment of various neurological disorders. New benzothiazole molecules are currently under development and are being evaluated for several uses including diagnostics and as therapeutic drug candidates for the treatment of epilepsy and neurodegenerative diseases such as Alzheimer's disease, Huntington's disease and amyotrophic lateral sclerosis amongst others.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15031582
- 003
- CZ-PrNML
- 005
- 20151007122116.0
- 007
- ta
- 008
- 151005s2015 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2174/0929867322666141212120631 $2 doi
- 035 __
- $a (PubMed)25515509
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Hroch, Lukas
- 245 10
- $a Benzothiazoles - scaffold of interest for CNS targeted drugs / $c L. Hroch, L. Aitken, O. Benek, M. Dolezal, K. Kuca, F. Gunn-Moore, K. Musilek,
- 520 9_
- $a Benzothiazole compounds represent heterocyclic systems comprising a benzene ring fused with a thiazole ring containing nitrogen and sulphur in its structure. Besides the presence of a benzothiazole core in naturally occurring molecules, synthesized compounds containing a benzothiazole moiety in their structure proved to be a significant class of potential therapeutics, as they exhibit biological effects such as antitumor, antibacterial, antitubercular, antiviral, anthelmintic, antidiabetic and many others. Apart from the aforementioned peripheral or microbial active sites, benzothiazole analogues are also biologically active compounds in the central nervous system, where some approved drugs containing a benzothiazole moiety have already been identified and are used in the treatment of various neurological disorders. New benzothiazole molecules are currently under development and are being evaluated for several uses including diagnostics and as therapeutic drug candidates for the treatment of epilepsy and neurodegenerative diseases such as Alzheimer's disease, Huntington's disease and amyotrophic lateral sclerosis amongst others.
- 650 _2
- $a Alzheimerova nemoc $x farmakoterapie $x radioizotopová diagnostika $7 D000544
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antikonvulziva $x chemie $x diagnostické užití $x terapeutické užití $7 D000927
- 650 _2
- $a benzothiazoly $x chemie $x diagnostické užití $x terapeutické užití $7 D052160
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a neuroprotektivní látky $x chemie $x diagnostické užití $x terapeutické užití $7 D018696
- 650 _2
- $a kvantitativní vztahy mezi strukturou a aktivitou $7 D021281
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Aitken, Laura $7 gn_A_00002727
- 700 1_
- $a Benek, Ondrej
- 700 1_
- $a Dolezal, Martin
- 700 1_
- $a Kuca, Kamil
- 700 1_
- $a Gunn-Moore, Frank
- 700 1_
- $a Musilek, Kamil $u University of Hradec Kralove, Faculty of Science, Department of Chemistry, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic. kamil.musilek@gmail.com.
- 773 0_
- $w MED00001274 $t Current medicinal chemistry $x 1875-533X $g Roč. 22, č. 6 (2015), s. 730-47
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25515509 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20151005 $b ABA008
- 991 __
- $a 20151007122301 $b ABA008
- 999 __
- $a ok $b bmc $g 1092458 $s 914708
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 22 $c 6 $d 730-47 $i 1875-533X $m Current medicinal chemistry $n Curr Med Chem $x MED00001274
- LZP __
- $a Pubmed-20151005